The Lancet Neurology in conversation with
Un pódcast de The Lancet Group - Jueves
187 Episodo
-
Giuseppe Citerio on frailty and TBI
Publicado: 19/1/2022 -
Alberto Costa on memantine in adolescents and young adults with Down syndrome
Publicado: 20/12/2021 -
Olivier Rascol on amantadine for patients with movement disorders
Publicado: 17/11/2021 -
Antonio Uccelli on stems cells for MS
Publicado: 20/10/2021 -
Priya Palta on blood pressure control and cognitive decline
Publicado: 15/9/2021 -
Adam Boxer on tau biomarkers
Publicado: 18/8/2021 -
Irene Cortese on the difficulties of designing clinical trials
Publicado: 21/7/2021 -
Doug Turnbull on mitochondrial diseases in adults
Publicado: 16/6/2021 -
Geert Jan Biessels on predicting post-stroke cognitive impairment
Publicado: 19/5/2021 -
Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS
Publicado: 21/4/2021 -
Anne MacGregor on menstrual migraine
Publicado: 17/3/2021 -
Peter Rothwell on asymptomatic carotid stenosis and stroke
Publicado: 17/2/2021 -
Spinal cord injury and degenerative cervical myelopathy
Publicado: 20/1/2021 -
Genetic risk factors for sCJD
Publicado: 22/12/2020 -
Prednisone in short-term prevention of cluster headache
Publicado: 24/11/2020 -
PET imaging of inflammation in neurological and psychiatric disorders
Publicado: 21/10/2020 -
Neurological associations of COVID-19
Publicado: 4/9/2020 -
Advances in understanding of Rett syndrome
Publicado: 31/7/2020 -
Management of Parkinson's disease
Publicado: 17/6/2020 -
Optimal time to treat Huntington's Disease
Publicado: 26/5/2020
Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.